文献速递妇科

症状性顶端盆腔器官脱垂的手术治疗:系统综述与荟萃分析

Surgical Management of Symptomatic Apical Pelvic Organ Prolapse: A Systematic Review and Meta-analysis.
PubMed 文献 · Obstet Gynecol · 2021-01-01

阴道悬吊术相比骶骨固定术的总体和解剖学顶端复发风险更高,微创骶骨固定术相比开腹骶骨固定术的总体和后壁解剖复发风险更低;多数术式间主观复发、再干预和并发症相似。

要点

  • 阴道悬吊术的总体解剖复发(RR 1.82)和顶端解剖复发(RR 2.70)风险高于骶骨固定术。
  • 微创骶骨固定术的总体解剖复发(RR 0.59)和后壁解剖复发(RR 0.59)风险低于开腹骶骨固定术。
  • 不同阴道术式及是否切除子宫的解剖成功率相似,主观复发与并发症多相似。

核心结论

  • 尽管解剖学结局存在差异,顶端POP手术在1-5年时主观结局和并发症相似。
  • 亟需标准化结局报告和更长随访的比较研究。

研究设计与样本

  • 系统综述与荟萃分析,检索MEDLINE、CENTRAL、ClinicalTrials.gov和EMBASE(2002-2019)。
  • 纳入随机对照试验和比较性研究,涵盖经腹(开腹、腹腔镜或机器人)及经阴道顶端重建,伴或不伴子宫切除。
  • 排除经阴道网片、退市产品、无顶端悬吊的修复及随访不足6个月的研究。
  • 采用相对危险度(RR)合并效应,使用GRADE系统评价质量及PRISMA报告规范。

主要发现

  • 阴道悬吊术相比骶骨固定术:总体解剖复发RR 1.82(95% CI 1.22-2.74),顶端解剖复发RR 2.70(95% CI 1.33-5.50)(中等质量)。
  • 微创骶骨固定术相比开腹骶骨固定术:总体解剖复发RR 0.59(95% CI 0.47-0.75),后壁解剖复发RR 0.59(95% CI 0.44-0.80)(低质量)。
  • 不同阴道术式之间、以及子宫切除加悬吊与子宫固定术之间,解剖成功率相似。
  • 多数术式间主观POP复发、因复发再干预及并发症相似。
  • 研究质量、技术和结局报告存在异质性,中位随访1-5年。

关键数值与推荐

  • 阴道悬吊术 vs 骶骨固定术:总体解剖复发RR 1.82(95% CI 1.22-2.74),顶端解剖复发RR 2.70(95% CI 1.33-5.50)。
  • 微创骶骨固定术 vs 开腹骶骨固定术:总体解剖复发RR 0.59(95% CI 0.47-0.75),后壁解剖复发RR 0.59(95% CI 0.44-0.80)。

临床怎么用

  • 选择顶端脱垂术式时,应告知患者阴道悬吊术的解剖复发风险高于骶骨固定术。
  • 微创骶骨固定术在解剖复发方面可能优于开腹骶骨固定术,但证据质量低。
  • 主观结局和并发症在多数术式间相似,术式选择需结合解剖结局与患者因素。

局限性

  • 研究质量、所用技术和结局报告存在异质性。
  • 中位随访仅1-5年,缺乏长期比较数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To systematically review objective and subjective success and complications of apical suspensions for symptomatic uterine or vaginal vault pelvic organ prolapse (POP). DATA SOURCES: MEDLINE, CENTRAL, ClinicalTrials.gov, and EMBASE (2002-2019) were searched using multiple terms for apical POP surgeries, including comparative studies in French and English. METHODS OF STUDY SELECTION: From 2,665 records, we included randomized controlled trials and comparative studies of interventions with or without hysterectomy, including abdominal apical reconstruction through open, laparoscopic, or robotic approaches and vaginal apical reconstructions. Repairs using transvaginal mesh, off-the-market products, procedures without apical suspension, and follow-up less than 6 months were excluded. TABULATION, INTEGRATION, AND RESULTS: Relative risk (RR) was used to estimate the effect of surgical procedure on each outcome. For each outcome and comparison, a meta-analysis was conducted to pool the RRs when possible. Meta-regression and bias tests were performed when appropriate. The GRADE (Grades for Recommendation, Assessment, Development and Evaluation) system for quality rating and PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) reporting were used. Sixty-two articles were included in the review (N=22,792) and 50 studies in the meta-analyses. There was heterogeneity in study quality, techniques used, and outcomes reported. Median follow-up was 1-5 years. Vaginal suspensions showed higher risk of overall and apical anatomic recurrence compared with sacrocolpopexy (RR 1.82, 95% CI 1.22-2.74 and RR 2.70, 95% CI 1.33-5.50) (moderate), whereas minimally invasive sacrocolpopexy showed less overall and posterior anatomic recurrence compared with open sacrocolpopexy (RR 0.59, 95% CI 0.47-0.75 and RR 0.59, 95% CI 0.44-0.80, respectively) (low). Different vaginal approaches, and hysterectomy and suspension compared with hysteropexy had similar anatomic success. Subjective POP recurrence, reintervention for POP recurrence and complications were similar between most procedures. CONCLUSION: Despite variations in anatomic outcomes, subjective outcomes and complications were similar for apical POP procedures at 1-5 years. Standardization of outcome reporting and comparative studies with longer follow-up are urgently needed. SYSTEMATIC REVIEW REGISTRATION: PROSPERO, CRD42019133869.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Larouche M, Belzile E, Geoffrion R, et al. Surgical Management of Symptomatic Apical Pelvic Organ Prolapse: A Systematic Review and Meta-analysis. Obstet Gynecol. 2021. PMID: 33957652. doi:10.1097/AOG.0000000000004393

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。